Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4Lymphoid 2Genitourinary 2Tumor-Agnostic 1Thoracic 1NET 1Endocrine 1

Conditions

Neoplastic Cells, Circulating 1Neoplasms 1Lung Neoplasms 1

Interventions

Carboplatin 1152Cisplatin 876Pemetrexed 834pembrolizumab 608Paclitaxel 598Docetaxel 535Gemcitabine 424Radiotherapy 377Erlotinib Hydrochloride 367Nivolumab 322Bevacizumab 322Etoposide 295durvalumab 254Drug Therapy 233osimertinib 218atezolizumab 208Radiosurgery 190Gefitinib 177Vinorelbine 145130-nm albumin-bound paclitaxel 124Magnetic Resonance Spectroscopy 121Ipilimumab 118Cetuximab 113anlotinib 104tislelizumab 103Topotecan 101Cyclophosphamide 101Taxes 99Irinotecan 95Albumin-Bound Paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Needles × Thoracic × Clear all
NCT02507778 2016-09-23

Circulating Tumor Cells Spillage After Pulmonary Biopsy

Rabin Medical Center

Phase NA Unknown
40 enrolled
Thoracic

Lung Neoplasms, Neoplastic Cells, Circulating, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡